Loading...
Docoh

Tactile Systems Technology (TCMD)

Tactile Medical is a leader in developing and marketing at-home therapy devices that treat chronic swelling conditions such as lymphedema and chronic venous insufficiency. Tactile Medical's Mission is to help people suffering from chronic diseases live better and care for themselves at home. The Company's unique offering includes advanced, clinically proven pneumatic compression devices, as well as continuity of care services provided by a national network of product specialists and trainers, reimbursement experts, patient advocates and clinicians. This combination of products and services ensures that tens of thousands of patients annually receive the at-home treatment necessary to better manage their chronic conditions. Tactile Medical takes pride in the fact that its solutions help increase clinical efficacy, reduce overall healthcare costs and improve the quality of life for patients with chronic conditions.

TCMD stock data

Analyst ratings and price targets

Last 3 months

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

1 Aug 22
13 Aug 22
31 Dec 22
Quarter (USD) Jun 22 Mar 22 Dec 21 Sep 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 23.35M 23.35M 23.35M 23.35M 23.35M 23.35M
Cash burn (monthly) (no burn) 2.14M 1.55M 1.48M (no burn) (no burn)
Cash used (since last report) n/a 3.12M 2.26M 2.15M n/a n/a
Cash remaining n/a 20.23M 21.09M 21.2M n/a n/a
Runway (months of cash) n/a 9.5 13.6 14.3 n/a n/a

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
8 Aug 22 Reuvers Daniel L. Common Stock Sell Dispose S No No 9.1801 1,020 9.36K 74,707
4 Aug 22 Burke William W Common Stock Buy Acquire P No No 9.15 4,900 44.84K 24,436
19 May 22 Burke William W Common Stock Sell Dispose S No Yes 10.12 1,100 11.13K 19,536
9 May 22 Huggenberger Raymond Common Stock Grant Acquire A No No 0 12,103 0 22,036
9 May 22 Deepti Jain Common Stock Grant Acquire A No No 0 12,103 0 15,448
90.6% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 125 128 -2.3%
Opened positions 22 27 -18.5%
Closed positions 25 38 -34.2%
Increased positions 45 40 +12.5%
Reduced positions 44 41 +7.3%
13F shares Current Prev Q Change
Total value 367.8M 851.17M -56.8%
Total shares 18.25M 18.33M -0.5%
Total puts 0 0
Total calls 200 9.1K -97.8%
Total put/call ratio
Largest owners Shares Value Change
BLK Blackrock 3.76M $75.9M +0.8%
Champlain Investment Partners 1.76M $35.39M -1.7%
MS Morgan Stanley 1.72M $34.74M -0.6%
Geneva Capital Management 1.39M $28M +4.6%
Vanguard 1.34M $27.01M +9.8%
STT State Street 945K $19.05M -12.3%
Point72 Asset Management 786.8K $15.86M NEW
Fort Washington Investment Advisors 443.41K $8.94M +17.5%
Geode Capital Management 333.67K $6.73M +1.0%
Healthcare Of Ontario Pension Plan Trust Fund 319.8K $6.45M NEW
Largest transactions Shares Bought/sold Change
Point72 Asset Management 786.8K +786.8K NEW
Trigran Investments 0 -545.27K EXIT
MCQEF Macquarie 71.48K -505.43K -87.6%
Nuveen Asset Management 85.41K -331.29K -79.5%
Healthcare Of Ontario Pension Plan Trust Fund 319.8K +319.8K NEW
SAMG Silvercrest Asset Management 0 -187.19K EXIT
Brandywine Global Investment Management 303.4K +146.86K +93.8%
Citadel Advisors 189.24K +145.37K +331.4%
STT State Street 945K -132.93K -12.3%
Tamarack Advisers 122.76K +122.76K NEW

Financial report summary

?
Competition
Electromed
Management Discussion
  • Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
  • The United States economy in general and our business specifically have been negatively affected by the COVID-19 pandemic. We have seen adverse impacts as it relates to the decline in the number of patients that healthcare facilities and clinics are able to treat due to enhanced safety protocols, particularly during most of 2021 and during the first quarter of 2022. We have also seen staffing challenges, both in our organization and at the clinics we serve, as another consequence of the COVID-19 pandemic. While we saw some level of recovery in the second quarter of 2022, there are no reliable estimates of how long the pandemic will last, whether any recovery will be sustained or will reverse course, the severity of any resurgence of COVID-19 or variant strains of the virus, the effectiveness of vaccines and attitudes towards receiving them, or what ultimate effects the pandemic will have. For that reason, we are unable to reasonably estimate the long-term impact of the pandemic on our business at this time.
  • Since the onset of COVID-19, we have remained proactive to ensure we continue to adapt to the needs of our employees, clinicians and patients. However, we cannot assure you these changes to our processes and practices will be successful in mitigating the impact of COVID-19 on our business. We continue to evaluate and, if appropriate, will adopt other measures in the future related to the ongoing safety of our employees, clinicians and patients.

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Good
New words: app, breached, declaration, director, easier, employment, enriched, fact, fiduciary, introduction, Jack, Kylee, mobile, Moen, nominal, PHE, proxy, purportedly, rescinded, staffing, stockholder, tracking, unjustly, unspecified, Weaver
Removed: comprehensive, enterprise, external, flexibility, heavily, lieu, payout, retainer, select, substantial, vast, virtual